Down syndrome serum screening also identifies an increased risk for multicystic dysplastic kidney, two‐vessel cord, and hydrocele
- 25 November 2008
- journal article
- research article
- Published by Wiley in Prenatal Diagnosis
- Vol. 28 (13) , 1204-1208
Abstract
Objective The FASTER trial compared first and second trimester screening methods for aneuploidy. We examined relationships between maternal serum markers and common congenital anomalies in the pediatric outcome data set of 36 837 subjects. Methods We used nested case–control studies, with cases defined by the most common anomalies in our follow‐up database, and up to four controls matched by enrollment site, maternal age and race, enrollment gestational age, and infant gender. Serum markers were dichotomized to ≥ 2 or < 0.5 multiples of the median (MoM). Odds ratios (ORs) and 95% confidence intervals (CI) were estimated. Results Statistically significant (p < 0.05) associations were found between inhibin A ≥ 2 MoM with fetal multicystic dysplastic kidney (MCDK) (OR = 27.5, 95% CI: 2.8–267.7) and two‐vessel cord (OR = 4.22, 95% CI:1.6–10.9); hCG of ≥ 2 MoM with MCDK (OR = 19.56, 95% CI: 1.9–196.2) and hydrocele (OR = 2.48, 95% CI: 1.3–4.6); and PAPP‐A ≥ 2.0 MoM with hydrocele (OR = 1.88, 95% CI:1.1–3.3). Conclusion In this large prospective study, significant associations were found between several maternal serum markers and congenital anomalies. This suggests potential additional benefits to screening programs that are primarily designed to detect aneuploidy. Copyright © 2008 John Wiley & Sons, Ltd.Keywords
Funding Information
- NIH HD (R01 38652)
- RR (M01 00054)
This publication has 13 references indexed in Scilit:
- Maternal serum screening and 22q11.2 deletion syndromeAmerican Journal of Medical Genetics Part A, 2007
- Identifying Smith–Lemli–Opitz syndrome in conjunction with prenatal screening for Down syndromePrenatal Diagnosis, 2006
- First-Trimester or Second-Trimester Screening, or Both, for Down's SyndromeNew England Journal of Medicine, 2005
- First-Trimester Septated Cystic HygromaObstetrics & Gynecology, 2005
- Quad Screen as a Predictor of Adverse Pregnancy OutcomeObstetrics & Gynecology, 2005
- Lack of correlation between elevated maternal serum hCG during second-trimester biochemical screening and fetal congenital anomalyPrenatal Diagnosis, 2005
- Assigning risk for Smith-Lemli-Opitz syndrome as part of 2nd trimester screening for Down's syndromeJournal of Medical Screening, 2002
- Second-trimester pregnancy associated plasma protein-A levels are reduced in Cornelia de Lange syndrome pregnancies.1999
- Fetal Smith-Lemli-Opitz syndrome can be detected accurately and reliably by measuring amniotic fluid dehydrocholesterolsPrenatal Diagnosis, 1998
- Maternal serum marker levels in two pregnancies affected with Smith-Lemli-Opitz syndrome.1997